Elevance Health (ELV) ebitda was $7.6B in FY2025 (-7% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$7.6B
-7%
2024
$8.2B
-8%
2023
$8.9B
+3%
2022
$8.7B
+9%
2021
$8.0B
+23%
2019
$6.4B
+11%
2018
$5.8B
+30%
2017
$4.5B
-12%
2016
$5.1B
+1%
2015
$5.0B
+7%
2014
$4.7B
+10%
2013
$4.3B
+10%
2012
$3.9B
-3%
2011
$4.0B
-7%
2010
$4.3B
-3%
2009
$4.4B
-4%
2008
$4.6B
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$1.9B
Q1 2026
$2.3B
Q4 2025
-$31M
Q3 2025
$1.5B
Q2 2025
$2.7B
Q1 2025
$3.4B
Q4 2024
$349M
Q3 2024
$1.6B
Q2 2024
$3.0B
Q1 2024
$3.2B
Q4 2023
$1.0B
Q3 2023
$2.8B
Source: ELV on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.